To The Moon

Moderna Inc.’s stock rose 1.1% early Friday, after the biotech said an advisory panel to the European Union’s medical regulator had adopted a positive opinion on its respiratory syncytial virus vaccine for adults aged 60 and older. The vaccine called mResvia has already been approved by the U.S. Food and Drug Administration, becoming Moderna’s second approved product after its COVID-19 vaccine, Spikevax. “mRESVIA safeguards older adults against severe RSV outcomes and is uniquely offered in a p

AMD is a global semiconductor company offering various products for data centers and personal computers.Under the leadership of CEO Dr. Lisa Su, AMD experienced significant growth, but the last two fi

Wall Street analyst consensus estimates FY 2026 will DOUBLE FY 2024 levels , which should outline a near TRIPLE of 2022-23 numbers. With all the euphoria floating around this stock, mentioning the fact competition may not allow such a large increase instantly gets booed as impossible. That's how investors think during the tail-end of an incredible upsurge for a particular stock or industry. Seeking Alpha Table - NVIDIA, Analyst Estimates for FY 2024-26, Made February 1st, 2024 For a forward 1-year valuation on projected earnings yield, bulls point to the fact that 2025-26 numbers should provide a decent 3% to 4% rate for buyers around $600 per share today. I will admit if the current forecast for growth comes to fruition,

The Chinese electric vehicle stock looks cheap now.

NIO reported a significant increase in vehicle sales and revenue for Q3 2023, but experienced a decrease in gross profit and a net loss.The company launched new products and announced cooperation agre